ALL

Oncology

Prevalence

75.0 / 100K

Incidence

47.0 / 100K/yr

1118 drugs in development·292 companies·2 clinical trials

Drug Pipeline by Phase

Approved(201)

Drug	Company
abrilada	PFIZER INC (PFE)
aBSI (Automated Bone Scan Index)	Lantheus Holdings, Inc. (LNTH)
acam2000	Emergent BioSolutions Inc. (EBS)
acetylcysteine	ENGENE HOLDINGS INC. (ENGN)
afinitor	Novartis AG (NVS)
Alimta®	ELI LILLY & Co (LLY)
almotriptan malate	Mylan II B.V. (MYL)
AMNIOCORD	MiMedx Group Inc (MDXG)
AMNIOEFFECT	MiMedx Group Inc (MDXG)
AMVUTTRA	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
astepro	Viatris Inc (VTRS)
atomoxetine	DR REDDYS LABORATORIES LTD (RDY)
atomoxetine	Aptinyx Inc. (APTX)
atomoxetine	Teva Pharmaceutical Industries Limited (TEVA)
aucatzyl	Autolus Therapeutics plc (AUTL)
aveed	Endo LP (NDOI)
Aybintio (SB8)	Organon & Co. (OGN)
azelastine	Amneal Pharmaceuticals, Inc. (AMRX)
baclofen	Impax Laboratories, LLC (IPXL)
BRIUMVI	TG THERAPEUTICS, INC. (TGTX)
bupivacaine	Spero Therapeutics, Inc. (SPRO)
bupropion	Impax Laboratories, LLC (IPXL)
buspirone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
busulfan	NEXUS BIOPHARMA INC (NEXS)
busulfan	Amneal Pharmaceuticals, Inc. (AMRX)
butalbital	QIAGEN N.V. (QGEN)
butalbital	Optec International, Inc. (GM)
butalbital	LANNETT CO INC (LCI)
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
carvedilol	Teva Pharmaceutical Industries Limited (TEVA)
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
cetirizine hydrochloride allergy	PERRIGO Co plc (PRGO)
Chenodal	Mirum Pharmaceuticals, Inc. (MIRM)
chenodiol	Optec International, Inc. (GM)
children's cetirizine hydrochloride hives relief	TESARO, Inc. (TSRO)
clonoSEQ	Adaptive Biotechnologies Corp (ADPT)
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)
colestipol	ANI PHARMACEUTICALS INC (ANIP)
cosela	G1 Therapeutics, Inc. (GTHX)
cromolyn	AGILE THERAPEUTICS INC (AGRX)
Cyramza	ELI LILLY & Co (LLY)
danyelza	Y-mAbs Therapeutics, Inc. (YMAB)
Delstrigo	Merck & Co., Inc. (MRK)
desloratadine	PERRIGO Co plc (PRGO)
dexlansoprazole	Mylan II B.V. (MYL)
dexmedetomidine	Mylan II B.V. (MYL)
dimethyl	Mylan II B.V. (MYL)
diphenhydramine	ACHIEVE LIFE SCIENCES, INC. (ACHV)
diphenhydramine	Miromatrix Medical Inc. (MIRO)
docetaxel	Amneal Pharmaceuticals, Inc. (AMRX)
docetaxel	PFIZER INC (PFE)
dsuvia	Verrica Pharmaceuticals Inc. (VRCA)
Ebglyss	ELI LILLY & Co (LLY)
Ebglyss®	ELI LILLY & Co (LLY)
elahere	ImmunoGen, Inc. (IMGN)
eligen b12 rx	EMISPHERE TECHNOLOGIES INC (EMIS)
emerphed	NEXUS BIOPHARMA INC (NEXS)
emrelis	AbbVie Inc. (ABBV)
EPICORD	MiMedx Group Inc (MDXG)
Erivedge	CURIS INC (CRIS)
esomeprazole magnesium	EXELIXIS, INC. (EXEL)
evomela	CASI Pharmaceuticals, Inc (DE) (CASI)
exforge hct	Novartis AG (NVS)
fexofenadine	PERRIGO Co plc (PRGO)
fexofenadine	DR REDDYS LABORATORIES LTD (RDY)
fingolimod	Aptinyx Inc. (APTX)
fingolimod	DR REDDYS LABORATORIES LTD (RDY)
fingolimod	Teva Pharmaceutical Industries Limited (TEVA)
fingolimod	SUNSET ISLAND GROUP (SUN)
fingolimod	ICON plc (ICLR)
fingolimod	aTYR PHARMA INC (ATYR)
fingolimod	Mylan II B.V. (MYL)
fingolimod	GT Biopharma, Inc. (GTBP)
fluconazole	ANI PHARMACEUTICALS INC (ANIP)
fosphenytoin	Amneal Pharmaceuticals, Inc. (AMRX)
fulphila	Mylan II B.V. (MYL)
gavreto	RIGEL PHARMACEUTICALS INC (RIGL)
GilvetMab	Merck & Co., Inc. (MRK)
GIVLAARI	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
glycopyrrolate	Amneal Pharmaceuticals, Inc. (AMRX)
guaifenesin	SUNSET ISLAND GROUP (SUN)
guaifenesin	PERRIGO Co plc (PRGO)
guaifenesin	DR REDDYS LABORATORIES LTD (RDY)
guanfacine	Nascent Biotech Inc. (NBIO)
guanfacine	Impax Laboratories, LLC (IPXL)
hydrocortisone	Aptinyx Inc. (APTX)
hydroxyurea	AVEDRO INC (AVDR)
ibrance	PFIZER INC (PFE)
ibtrozi	Nuvation Bio Inc. (NUVB)
ibuprofen	DR REDDYS LABORATORIES LTD (RDY)
ibuprofen	PERRIGO Co plc (PRGO)
Imdelltra	Royalty Pharma plc (RPRX)
imipramine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
INVEGA HAFYERA / BYANNLI	Alkermes plc. (ALKS)
INVEGA TRINZA / TREVICTA	Alkermes plc. (ALKS)
ipratropium	Amneal Pharmaceuticals, Inc. (AMRX)
iv tpoxx	SIGA TECHNOLOGIES INC (SIGA)
Jaypirca	ELI LILLY & Co (LLY)
Jaypirca®	ELI LILLY & Co (LLY)
Karbinal ER	AYTU BIOPHARMA, INC (AYTU)
krazati	Mirati Therapeutics, Inc. (MRTX)
krazati	BRISTOL MYERS SQUIBB CO (BMY)
lamotrigine	Teva Pharmaceutical Industries Limited (TEVA)
leucovorin calcium preservative free	Mylan II B.V. (MYL)
leucovorin calcium preservative free	Seagen Inc. (SGEN)
leuprolide	SUNSET ISLAND GROUP (SUN)
liberty endovascular robotic surgical system	Microbot Medical Inc. (MBOT)
loqtorzi	Coherus Oncology, Inc. (CHRS)
loratadine	PERRIGO Co plc (PRGO)
loratadine redidose	SUNSET ISLAND GROUP (SUN)
lorazepam	ANI PHARMACEUTICALS INC (ANIP)
lorbrena	PFIZER INC (PFE)
loteprednol etabonate	Amneal Pharmaceuticals, Inc. (AMRX)
luxturna	Spark Therapeutics, Inc. (SPARK)
lymphoseek kit	Cardinal Health Inc. (CAH)
magnesium	Spero Therapeutics, Inc. (SPRO)
medroxyprogesterone	Amphastar Pharmaceuticals, Inc. (AMPH)
metastron	Q BioMed Inc. (QBIO)
methotrexate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
methylprednisolone	Amneal Pharmaceuticals, Inc. (AMRX)
miglustat	ANI PHARMACEUTICALS INC (ANIP)
mycophenolate mofetil	Amneal Pharmaceuticals, Inc. (AMRX)
naftifine	Amneal Pharmaceuticals, Inc. (AMRX)
naproxen	Amneal Pharmaceuticals, Inc. (AMRX)
nasonex 24hr allergy	PERRIGO Co plc (PRGO)
nda	Aquestive Therapeutics, Inc. (AQST)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
neffy (EURneffy in EU)	ARS Pharmaceuticals, Inc. (SPRY)
nelarabine	Amneal Pharmaceuticals, Inc. (AMRX)
nelarabine	NEXUS BIOPHARMA INC (NEXS)
neoprofen	Ultragenyx Pharmaceutical Inc. (RARE)
Ocular Immunoglobulin E (IgE)	AXIM BIOTECHNOLOGIES, INC. (AXIM)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
olopatadine	Amneal Pharmaceuticals, Inc. (AMRX)
ONPATTRO	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
ovawatch	Aspira Women's Health Inc. (AWHL)
ovitex	TELA Bio Inc. (TELA)
OXLUMO	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
paclitaxel	Mylan II B.V. (MYL)
palforzia	Aimmune Therapeutics, Inc. (AIMT)
pemetrexed	DR REDDYS LABORATORIES LTD (RDY)
pemfexy	EAGLE PHARMACEUTICALS, INC. (EGRX)
Pifeltro	Merck & Co., Inc. (MRK)
plegridy	BIOGEN INC. (BIIB)
polyethylene glycol 3350	ANI PHARMACEUTICALS INC (ANIP)
polyethylene glycol 3350	Mylan II B.V. (MYL)
polyethylene glycol 3350	Optec International, Inc. (GM)
ponvory	Vanda Pharmaceuticals Inc. (VNDA)
portrazza	ELI LILLY & Co (LLY)
pravastatin	Aptinyx Inc. (APTX)
prednisone	DR REDDYS LABORATORIES LTD (RDY)
prehevbrio	VBI VACCINES INC/BC (VBIV)
Prevymis	Merck & Co., Inc. (MRK)
procainamide	NEXUS BIOPHARMA INC (NEXS)
promacta	Novartis AG (NVS)
Purified Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)
rivfloza	Novo Nordisk A/S (NVO)
romvimza	Deciphera Pharmaceuticals, Inc. (DCPH)
rylaze	Jazz Pharmaceuticals plc (JAZZ)
Rylaze / Enrylaze	Jazz Pharmaceuticals plc (JAZZ)
simpligraft	Xtant Medical Holdings, Inc. (XTNT)
simplimax	Xtant Medical Holdings, Inc. (XTNT)
sincalide	MAIA Biotechnology, Inc. (MAIA)
sirolimus	Amneal Pharmaceuticals, Inc. (AMRX)
strontium-89	Q BioMed Inc. (QBIO)
tacrolimus	Mylan II B.V. (MYL)
tacrolimus	NEXUS BIOPHARMA INC (NEXS)
tascenso odt	BICYCLE THERAPEUTICS PLC (BCYC)
telmisartan	Inventiva S.A. (IVA)
tembexa	Emergent BioSolutions Inc. (EBS)
teriflunomide	Mersana Therapeutics, Inc. (MRSN)
teriflunomide	Aptinyx Inc. (APTX)
testosterone	Amneal Pharmaceuticals, Inc. (AMRX)
tpoxx	SIGA TECHNOLOGIES INC (SIGA)
triamcinolone acetonide	Aptinyx Inc. (APTX)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
triamcinolone acetonide	PERRIGO Co plc (PRGO)
Triamcinolone Acetonide and Neomycin Paste	China Health Industries Holdings, Inc. (CHHE)
trientine	Amneal Pharmaceuticals, Inc. (AMRX)
trimipramine	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
trodelvy	Immunome Inc. (IMNM)
udenyca	Coherus Oncology, Inc. (CHRS)
unloxcyt	Checkpoint Therapeutics, Inc. (CKPT)
unloxcyt	Fortress Biotech Inc. (FBIO)
unloxcyt	Fortress Biotech Inc. (FBIO)
ursodiol	Optec International, Inc. (GM)
vascepa	AMARIN CORP PLCUK (AMRN)
VASCEPA (VAZKEPA in EU)	AMARIN CORP PLCUK (AMRN)
VASCEPA (VAZKEPA)	AMARIN CORP PLCUK (AMRN)
VELDONA Pet supplement	Ainos Inc. (AIMD)
venetoclax	DR REDDYS LABORATORIES LTD (RDY)
venlafaxine	Teva Pharmaceutical Industries Limited (TEVA)
vigiv cnj-016	Emergent BioSolutions Inc. (EBS)
vizimpro	PFIZER INC (PFE)
VUMERITY	Alkermes plc. (ALKS)
zejula	TESARO, Inc. (TSRO)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)
Zepzelca	Jazz Pharmaceuticals plc (JAZZ)
zerviate	HARROW, INC. (IMMY)
ZYNYZ	MACROGENICS INC (MGNX)

Phase 3(316)

Drug	Company
(osimertinib cohort	ASTRAZENECA PLC (AZN)
[177Lu]Lu-DOTA-TATE	Novartis AG (NVS)
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
aav2-hrpe65v2	Spark Therapeutics, Inc. (SPARK)
abp 234	AMGEN INC (AMGN)
acasunlimab	Genmab A/S (GMAB)
Adagrasib	ENANTA PHARMACEUTICALS INC (ENTA)
ak112	Summit Therapeutics Inc. (SMMT)
AK112 Injection	Summit Therapeutics Inc. (SMMT)
Alectinib	Nuvalent, Inc. (NUVL)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
Amivantamab	Merus N.V. (MRUS)
amivantamab sc	GH Research PLC (GHRS)
Amrubicin	Merus N.V. (MRUS)
Amrubicin	Merck & Co., Inc. (MRK)
an2025	Adlai Nortye Ltd. (ANL)
Anaphylm™	Aquestive Therapeutics, Inc. (AQST)
apg-1252	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
AR-320	Aridis Pharmaceuticals, Inc. (ARDS)
aumolertinib	EQRx, Inc. (EQRX)
autologous	ASTRAZENECA PLC (AZN)
avelumab	GH Research PLC (GHRS)
Avelumab	Merck & Co., Inc. (MRK)
avutometinib	Verastem, Inc. (VSTM)
AXAL (axalimogene filolisbac / ADXS-HPV)	Ayala Pharmaceuticals, Inc. (ADXS)
azacytidine	Merus N.V. (MRUS)
azd0171	ASTRAZENECA PLC (AZN)
azd0240	ASTRAZENECA PLC (AZN)
AZD0486	ASTRAZENECA PLC (AZN)
AZD2936	ASTRAZENECA PLC (AZN)
AZD5305	ASTRAZENECA PLC (AZN)
AZD5335	ASTRAZENECA PLC (AZN)
AZD8205 and AZD5305	ASTRAZENECA PLC (AZN)
AZD8205 and AZD5305 and AZD2936	ASTRAZENECA PLC (AZN)
azd9291	ASTRAZENECA PLC (AZN)
azd9291 80 mg/40 mg	ASTRAZENECA PLC (AZN)
Background Chemotherapy	Merus N.V. (MRUS)
Bendamustine	ENANTA PHARMACEUTICALS INC (ENTA)
bgb-15025	BeOne Medicines Ltd. (ONC)
BGB-15025	BeOne Medicines Ltd. (ONC)
BGB-16673	Merus N.V. (MRUS)
BGB-16673	ENANTA PHARMACEUTICALS INC (ENTA)
bgb-a445	BeOne Medicines Ltd. (ONC)
BGB-A445	BeOne Medicines Ltd. (ONC)
blinatumomab	AMGEN INC (AMGN)
Cabozantinib	Royalty Pharma plc (RPRX)
Calderasib	Merck & Co., Inc. (MRK)
CAN-2409	Candel Therapeutics, Inc. (CADL)
canakinumab	Novartis AG (NVS)
Capivasertib	ASTRAZENECA PLC (AZN)
capmatinib	GH Research PLC (GHRS)
CAR-T	Valneva SE (VALN)
Ceftriaxone 2g diluted in >200ml 0.9%sodium chloride	Valneva SE (VALN)
cemiplimab	GH Research PLC (GHRS)
Cemiplimab	ENANTA PHARMACEUTICALS INC (ENTA)
Ceralasertib	Relay Therapeutics, Inc. (RLAY)
Ceralasertib	ENANTA PHARMACEUTICALS INC (ENTA)
Ceralasertib	ASTRAZENECA PLC (AZN)
Ceralasertib	Crinetics Pharmaceuticals, Inc. (CRNX)
Ceralasertib	ADMA BIOLOGICS, INC. (ADMA)
Cetuximab	ENANTA PHARMACEUTICALS INC (ENTA)
Cetuximab	FATE THERAPEUTICS INC (FATE)
Cetuximab Sarotalocan Sodium	FATE THERAPEUTICS INC (FATE)
chemotherapy	GH Research PLC (GHRS)
chemotherapy agents	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
clobetasol	GH Research PLC (GHRS)
cobolimab	ANAPTYSBIO, INC (ANAB)
Concurrent chemotherapy	Crinetics Pharmaceuticals, Inc. (CRNX)
Crizotinib	Nuvation Bio Inc. (NUVB)
Crizotinib	BRISTOL MYERS SQUIBB CO (BMY)
custirsen	ACHIEVE LIFE SCIENCES, INC. (ACHV)
daraxonrasib	REVOLUTION MEDICINES, INC. (RVMD)
Dato-DXd	ASTRAZENECA PLC (AZN)
datopotamab deruxtecan	ASTRAZENECA PLC (AZN)
Datopotamab Deruxtecan	Merus N.V. (MRUS)
Datopotamab Deruxtecan	Merck & Co., Inc. (MRK)
dbv712	DBV Technologies S.A. (DBVT)
degarelix	GH Research PLC (GHRS)
Divarasib	ENANTA PHARMACEUTICALS INC (ENTA)
DLI	Valneva SE (VALN)
Docetetaxel	Merck & Co., Inc. (MRK)
Domvanalimab	ASTRAZENECA PLC (AZN)
Dostarlimab	ANAPTYSBIO, INC (ANAB)
Dostarlimab and TSR-022	ANAPTYSBIO, INC (ANAB)
drug	ImmunityBio, Inc. (IBRX)
eftilagimod alfa	Immutep Limited (IMMP)
eftilagimod alfa	IMMUTEP Ltd (PRRUF)
Eftilagimod Alfa	Immutep Limited (IMMP)
egfr-tki inhibitor based on investigator's choice	ArriVent BioPharma, Inc. (AVBP)
elironrasib	REVOLUTION MEDICINES, INC. (RVMD)
Ensartinib	Merus N.V. (MRUS)
Ensartinib	ENANTA PHARMACEUTICALS INC (ENTA)
Entrectinib	Merus N.V. (MRUS)
EPX-100	Harmony Biosciences Holdings, Inc. (HRMY)
Erlotinib	Amneal Pharmaceuticals, Inc. (AMRX)
Erlotinib	Merus N.V. (MRUS)
Erlotinib	ENANTA PHARMACEUTICALS INC (ENTA)
erlotinib 150/100 mg	ASTRAZENECA PLC (AZN)
Erlotinib Hydrochloride	Amneal Pharmaceuticals, Inc. (AMRX)
etoposide	Black Diamond Therapeutics, Inc. (BDTX)
Etoposide	BioNTech SE (BNTX)
Etoposide	ADMA BIOLOGICS, INC. (ADMA)
ETOPOSIDE - Study	Design Therapeutics, Inc. (DSGN)
ETOPOSIDE - Usual	Design Therapeutics, Inc. (DSGN)
Etoposide Injection	ASTRAZENECA PLC (AZN)
Etoposide phosphate	Black Diamond Therapeutics, Inc. (BDTX)
fexofenadine	Sanofi (SNY)
fianlimab	REGENERON PHARMACEUTICALS, INC. (REGN)
firmonertinib	ArriVent BioPharma, Inc. (AVBP)
Firmonertinib	Relay Therapeutics, Inc. (RLAY)
Firmonertinib	Merus N.V. (MRUS)
Firmonertinib	ADMA BIOLOGICS, INC. (ADMA)
First-line Chemotherapy	Merus N.V. (MRUS)
FOLFIRI-HD	IGM Biosciences, Inc. (IGMS)
FOLFIRI+cetuximab	IGM Biosciences, Inc. (IGMS)
FOLFIRINOX chemotherapy	Merus N.V. (MRUS)
folfox	GH Research PLC (GHRS)
FOLFOX	KYNTRA BIO INC. (KYNB)
FOLFOX6/FOLFOX7	IGM Biosciences, Inc. (IGMS)
folinic acid	Merus N.V. (MRUS)
Four week alternating FOLFOX and FOLFIRI	IGM Biosciences, Inc. (IGMS)
furmonertinib	ArriVent BioPharma, Inc. (AVBP)
GDC-9545	ENANTA PHARMACEUTICALS INC (ENTA)
geo-mva	GeoVax Labs, Inc. (GOVX)
Giredestrant	ENANTA PHARMACEUTICALS INC (ENTA)
GnRH Agonist	ENANTA PHARMACEUTICALS INC (ENTA)
goserelin	GH Research PLC (GHRS)
goserelin	GH Research PLC (GHRS)
gotistobart	Onconetix, Inc. (ONCO)
Gotistobart	BioNTech SE (BNTX)
HER3-DXd	Merck & Co., Inc. (MRK)
Hyperthermic Intraperitoneal Chemotherapy	Merus N.V. (MRUS)
I-DXd	Merck & Co., Inc. (MRK)
iag	RenovoRx, Inc. (RNXT)
Idelalisib	ENANTA PHARMACEUTICALS INC (ENTA)
Immune Checkpoint Inhibitor	Merus N.V. (MRUS)
Immune Globulin Subcutaneous, 20% Solution	ENANTA PHARMACEUTICALS INC (ENTA)
Immune induction therapy	Crinetics Pharmaceuticals, Inc. (CRNX)
Immunomaintenance therapy	Crinetics Pharmaceuticals, Inc. (CRNX)
Inavolisib	ENANTA PHARMACEUTICALS INC (ENTA)
Intismeran autogene	Merck & Co., Inc. (MRK)
Intismeran autogene	Merus N.V. (MRUS)
intravenous immunoglobulins	GH Research PLC (GHRS)
Investigator's selection of appropriate chemotherapy regimen	Merus N.V. (MRUS)
Ipatasertib	ENANTA PHARMACEUTICALS INC (ENTA)
ivonescimab	Summit Therapeutics Inc. (SMMT)
Ivonescimab Injection	Summit Therapeutics Inc. (SMMT)
jcar017	Juno Therapeutics, Inc. (JUNO)
JCAR017 + venetoclax	Merus N.V. (MRUS)
JDQ443	Novartis AG (NVS)
kte-c19	Kite Pharma, Inc. (KITE)
l-leucovorin	Merus N.V. (MRUS)
Lartesertib	Merck & Co., Inc. (MRK)
Lazertinib	Merus N.V. (MRUS)
lbl-007	BeOne Medicines Ltd. (ONC)
LBL-007	BeOne Medicines Ltd. (ONC)
Lenvatinib	Merck & Co., Inc. (MRK)
leuprolide	GH Research PLC (GHRS)
leuprolide	GH Research PLC (GHRS)
LHRH Agonist	ENANTA PHARMACEUTICALS INC (ENTA)
ligelizumab	Novartis AG (NVS)
lou064	Novartis AG (NVS)
low-intensity chemotherapy regimen	AMGEN INC (AMGN)
Lurbinectedin	Crinetics Pharmaceuticals, Inc. (CRNX)
Lurbinectedin	Merck & Co., Inc. (MRK)
Lurbinectedin	Merus N.V. (MRUS)
LY3650150	ELI LILLY & Co (LLY)
Lymphodepleting chemotherapy	Merus N.V. (MRUS)
MEDI4736+Tremelimumab	ASTRAZENECA PLC (AZN)
MEDI5752	ASTRAZENECA PLC (AZN)
Melphalan	Filana Therapeutics Inc. (FLNA)
Mesna	Filana Therapeutics Inc. (FLNA)
minocycline	GH Research PLC (GHRS)
Mitomycin	KYNTRA BIO INC. (KYNB)
MK-0482	Merck & Co., Inc. (MRK)
MK-3475	Merck & Co., Inc. (MRK)
MK-4830	Merck & Co., Inc. (MRK)
Multikine	CEL SCI CORP (CVM)
nbtxr3	LianBio (LIANY)
Nelistotug	iTeos Therapeutics, Inc. (ITOS)
Neoadjuvant olaparib	ENANTA PHARMACEUTICALS INC (ENTA)
Nipocalimab	ENANTA PHARMACEUTICALS INC (ENTA)
Nipocalimab	ADMA BIOLOGICS, INC. (ADMA)
norditropin	Novo Nordisk A/S (NVO)
nvl-655	Nuvalent, Inc. (NUVL)
Obinutuzumab	ASTRAZENECA PLC (AZN)
ociperlimab	BeOne Medicines Ltd. (ONC)
olafertinib	Checkpoint Therapeutics, Inc. (CKPT)
olverembatinib	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
olverembatinib	CHINA PHARMA HOLDINGS, INC. (CPHI)
open-label azd9291 80 mg/40 mg	ASTRAZENECA PLC (AZN)
osimertinib	GH Research PLC (GHRS)
Osimertinib	Amneal Pharmaceuticals, Inc. (AMRX)
Osimertinib + Savolitinib	ASTRAZENECA PLC (AZN)
osimertinib 80 mg/40 mg	ASTRAZENECA PLC (AZN)
Panitumumab	IGM Biosciences, Inc. (IGMS)
part a - azd9291 in combination with continuous selumetinib	ASTRAZENECA PLC (AZN)
part a - azd9291 in combination with medi4736	ASTRAZENECA PLC (AZN)
part b - azd9291 in combination with medi4736	ASTRAZENECA PLC (AZN)
part b - azd9291 in combination with selumetinib	ASTRAZENECA PLC (AZN)
pemetrexed	Crinetics Pharmaceuticals, Inc. (CRNX)
pemetrexed	BeOne Medicines Ltd. (ONC)
pemetrexed	GILEAD SCIENCES, INC. (GILD)
pemetrexed	Incyte Corp. (INCY)
Pemetrexed	ENANTA PHARMACEUTICALS INC (ENTA)
Pemetrexed	Merck & Co., Inc. (MRK)
Pemetrexed	ELI LILLY & Co (LLY)
Pemetrexed	BRISTOL MYERS SQUIBB CO (BMY)
Pemetrexed Disodium	ADMA BIOLOGICS, INC. (ADMA)
Pemetrexed Disodium	ENANTA PHARMACEUTICALS INC (ENTA)
Pemetrexed Disodium	Merus N.V. (MRUS)
pg-011 nasal spray 0.6%	TG THERAPEUTICS, INC. (TGTX)
Physician's choice chemotherapy	Merus N.V. (MRUS)
platinum doublet	REGENERON PHARMACEUTICALS, INC. (REGN)
platinum-based chemotherapy	ArriVent BioPharma, Inc. (AVBP)
Plinabulin	BeyondSpring Inc. (BYSI)
plx-100	Polaryx Therapeutics Inc. (PLYX)
plx-300	Polaryx Therapeutics Inc. (PLYX)
posoleucel	Kalaris Therapeutics, Inc. (KLRS)
Pralsetinib	Merus N.V. (MRUS)
pumecitinib nasal spray 0.6%	TG THERAPEUTICS, INC. (TGTX)
ramucirumab	GH Research PLC (GHRS)
Ramucirumab	ASTRAZENECA PLC (AZN)
Reblozyl	Merck & Co., Inc. (MRK)
regn1908	REGENERON PHARMACEUTICALS, INC. (REGN)
regn1909	REGENERON PHARMACEUTICALS, INC. (REGN)
regn2810/chemo/ipi	REGENERON PHARMACEUTICALS, INC. (REGN)
regn5713	REGENERON PHARMACEUTICALS, INC. (REGN)
regn5715	REGENERON PHARMACEUTICALS, INC. (REGN)
regn7075	REGENERON PHARMACEUTICALS, INC. (REGN)
Relugolix	Myovant Sciences Ltd. (MYOV)
Relugolix Combination Tablet	Myovant Sciences Ltd. (MYOV)
Repotrectinib	BRISTOL MYERS SQUIBB CO (BMY)
reproxalap	Aldeyra Therapeutics, Inc. (ALDX)
Rescue Medication	Merus N.V. (MRUS)
Rescue Medications	Merck & Co., Inc. (MRK)
Rescue medications for chemotherapy	Merus N.V. (MRUS)
Rilvegostomig	ASTRAZENECA PLC (AZN)
rmc-4630	REVOLUTION MEDICINES, INC. (RVMD)
rmc-6236	REVOLUTION MEDICINES, INC. (RVMD)
rmc-6291	REVOLUTION MEDICINES, INC. (RVMD)
rmc-9805	REVOLUTION MEDICINES, INC. (RVMD)
Rucaparib	Merck & Co., Inc. (MRK)
sacituzumab govitecan	Phoenix Life Sciences International Limited. (PLSI)
Sacituzumab tirumotecan	Merck & Co., Inc. (MRK)
Sacituzumab tirumotecan	Merus N.V. (MRUS)
savolitinib	HUTCHMED (China) Limited (HCM)
savolitinib + osimertinib	HUTCHMED (China) Limited (HCM)
scd therapy	SeaStar Medical Holding Corporation (ICU)
Selpercatinib	ELI LILLY & Co (LLY)
Single-agent chemotherapy	Merus N.V. (MRUS)
sitravatinib	Mirati Therapeutics, Inc. (MRTX)
Sonrotoclax	ENANTA PHARMACEUTICALS INC (ENTA)
sotorasib	REVOLUTION MEDICINES, INC. (RVMD)
sunvozertinib	Merus N.V. (MRUS)
Supportive care measures	Merck & Co., Inc. (MRK)
Surovatamig	ASTRAZENECA PLC (AZN)
surzebiclimab	BeOne Medicines Ltd. (ONC)
SYS6010	Merus N.V. (MRUS)
t-dxd	ASTRAZENECA PLC (AZN)
Tacrolimus	Filana Therapeutics Inc. (FLNA)
tak-280	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-280	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-676	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-676	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-788	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-788	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Taletrectinib	Nuvation Bio Inc. (NUVB)
Tarlatamab	AMGEN INC (AMGN)
Telisotuzumab vedotin	AbbVie Inc. (ABBV)
tepotinib	GH Research PLC (GHRS)
Thiotepa	Filana Therapeutics Inc. (FLNA)
timing to initiate the adjuvant FOLFOX chemotherapy	Merus N.V. (MRUS)
tki	CHINA PHARMA HOLDINGS, INC. (CPHI)
tki	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Topotecan	Crinetics Pharmaceuticals, Inc. (CRNX)
Topotecan	Merus N.V. (MRUS)
Topotecan	Merck & Co., Inc. (MRK)
TQC2938 injection	Crinetics Pharmaceuticals, Inc. (CRNX)
Trametinib	Novartis AG (NVS)
tremelimumab	GH Research PLC (GHRS)
Tremelimumab	ASTRAZENECA PLC (AZN)
trilaciclib	G1 Therapeutics, Inc. (GTHX)
triptorelin	GH Research PLC (GHRS)
triptorelin	GH Research PLC (GHRS)
tsr-042	TESARO, Inc. (TSRO)
uft	ASTRAZENECA PLC (AZN)
Unrelated donor bone marrow transplant	Filana Therapeutics Inc. (FLNA)
V940	Merck & Co., Inc. (MRK)
vehicle	Aldeyra Therapeutics, Inc. (ALDX)
Venetoclax	Merus N.V. (MRUS)
Venetoclax	ASTRAZENECA PLC (AZN)
venetoclax 10 mg oral tablet [venclexta]	GH Research PLC (GHRS)
venetoclax 100 mg oral tablet [venclexta]	GH Research PLC (GHRS)
venetoclax 50 mg oral tablet [venclexta]	GH Research PLC (GHRS)
vepdegestrant	ARVINAS, INC. (ARVN)
Viaskin Milk	DBV Technologies S.A. (DBVT)
viaskin peanut	DBV Technologies S.A. (DBVT)
Viaskin Peanut	DBV Technologies S.A. (DBVT)
Vibostolimab	Merck & Co., Inc. (MRK)
vinflunine	Phoenix Life Sciences International Limited. (PLSI)
vinorelbine	ASTRAZENECA PLC (AZN)
vinorelbine	BRISTOL MYERS SQUIBB CO (BMY)
vinorelbine	MAIA Biotechnology, Inc. (MAIA)
Vinorelbine Tartrate	ENANTA PHARMACEUTICALS INC (ENTA)
virtue sab	Orchestra BioMed Holdings Inc. (OBIO)
Volrustomig	ASTRAZENECA PLC (AZN)
voretigene neparvovec	Novartis AG (NVS)
zipalertinib	Cullinan Therapeutics, Inc. (CGEM)
Zipalertinib (CLN-081/TAS6417)	Cullinan Therapeutics, Inc. (CGEM)
zl-1310	Zai Lab Ltd (ZLAB)
ZL-1310	Merus N.V. (MRUS)
zolbetuximab	Merus N.V. (MRUS)
zongertinib	Merus N.V. (MRUS)
Zongertinib	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2(236)

Drug	Company
[177Lu]Lu-DOTATATE	Novartis AG (NVS)
6-thio-2'-deoxyguanosine	MAIA Biotechnology, Inc. (MAIA)
AB-106	Nuvation Bio Inc. (NUVB)
ABBV-706	AbbVie Inc. (ABBV)
ABT-869	AbbVie Inc. (ABBV)
ABT-869 .25 mg/kg	AbbVie Inc. (ABBV)
ABT-869 0.10 mg/kg	AbbVie Inc. (ABBV)
acp-103	ACADIA PHARMACEUTICALS INC (ACAD)
Adavosertib	ADMA BIOLOGICS, INC. (ADMA)
Alectinib	Merus N.V. (MRUS)
alisertib	PUMA BIOTECHNOLOGY, INC. (PBYI)
alk202	SAB BIOTHERAPEUTICS, INC. (SABS)
ALLO-501A	Allogene Therapeutics, Inc. (ALLO)
ALLO-647	Allogene Therapeutics, Inc. (ALLO)
allonk	Artiva Biotherapeutics, Inc. (ARTV)
am0010	ARMO BIOSCIENCES, INC. (ARMO)
amg 436	AMGEN INC (AMGN)
amivantamab	ASTRAZENECA PLC (AZN)
Amivantamab	Structure Therapeutics Inc. (GPCR)
Amivantamab and Recombinant Human Hyaluronidase	FATE THERAPEUTICS INC (FATE)
Amivantamab and Recombinant Human Hyaluronidase	Structure Therapeutics Inc. (GPCR)
Amivantamab IV	Bausch Health Companies Inc. (BHC)
Amivantamab IV	Structure Therapeutics Inc. (GPCR)
Amivantamab SC	Bausch Health Companies Inc. (BHC)
Amivantamab SC	Structure Therapeutics Inc. (GPCR)
anti- human monoclonal antibody	Rallybio Corp (RLYB)
anti-cd20 car-t	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
anti-pd-1/l1	HUTCHMED (China) Limited (HCM)
anvumetostat	AMGEN INC (AMGN)
AR101	REGENERON PHARMACEUTICALS, INC. (REGN)
ar201	Aimmune Therapeutics, Inc. (AIMT)
atg	GH Research PLC (GHRS)
AUCATZYL/obe-cel	Autolus Therapeutics plc (AUTL)
Avelumab	NEKTAR THERAPEUTICS (NKTR)
azd2811	ASTRAZENECA PLC (AZN)
azd5305 microtracer	ASTRAZENECA PLC (AZN)
BDTX-1535	Black Diamond Therapeutics, Inc. (BDTX)
Blinatumomab	Merus N.V. (MRUS)
blu-808	Blueprint Medicines Corp (BPMC)
bnt116	REGENERON PHARMACEUTICALS, INC. (REGN)
BNT327 Dose Level 1	BioNTech SE (BNTX)
BNT327 Dose Level 2	BioNTech SE (BNTX)
BNT327 Equivalent Q3W Dose	BioNTech SE (BNTX)
BNT327 Optimized Dose	BioNTech SE (BNTX)
Boserolimab	Merus N.V. (MRUS)
Boserolimab	Merck & Co., Inc. (MRK)
Brigatinib	Merus N.V. (MRUS)
bruton's tyrosine kinase inhibitor	GH Research PLC (GHRS)
BT5528	BICYCLE THERAPEUTICS PLC (BCYC)
BT8009	BICYCLE THERAPEUTICS PLC (BCYC)
Cabozantinib	UNITED THERAPEUTICS Corp (UTHR)
canakinumab	Novartis AG (NVS)
capmatinib	Novartis AG (NVS)
capmatinib	Novartis AG (NVS)
cd19+	GH Research PLC (GHRS)
cd45ra-depleted dli	GH Research PLC (GHRS)
cemiplimab	MAIA Biotechnology, Inc. (MAIA)
Cemiplimab	FATE THERAPEUTICS INC (FATE)
Cemiplimab	Merus N.V. (MRUS)
Cemiplimab	ADMA BIOLOGICS, INC. (ADMA)
Cemiplimab	Royalty Pharma plc (RPRX)
Cemiplimab	Assertio Holdings, Inc. (ASRT)
Cemiplimab 350 mg IV	Merus N.V. (MRUS)
ceralasertib	GH Research PLC (GHRS)
Cetrelimab	ENANTA PHARMACEUTICALS INC (ENTA)
Cetrelimab	Janux Therapeutics, Inc. (JANX)
Cetuximab	Structure Therapeutics Inc. (GPCR)
chlorhexidine	GH Research PLC (GHRS)
Chlorhexidine	Structure Therapeutics Inc. (GPCR)
clindamycin	GH Research PLC (GHRS)
Clindamycin	Structure Therapeutics Inc. (GPCR)
Clobetasol	Structure Therapeutics Inc. (GPCR)
Clobetasol	Bausch Health Companies Inc. (BHC)
cnct19	CASI Pharmaceuticals, Inc (DE) (CASI)
Cobimetinib	Merus N.V. (MRUS)
concurrent chemo/radiation therapy	JOHNSON & JOHNSON (JNJ)
concurrent chemo/radiation therapy	Innovation Pharmaceuticals Inc. (IPIX)
Crizotinib	Amneal Pharmaceuticals, Inc. (AMRX)
ct053ptsa	SUNSHINE BIOPHARMA INC. (SBFM)
cylembio	IO Biotech, Inc. (IOBT)
Diclofenac Potassium	ENANTA PHARMACEUTICALS INC (ENTA)
direct oral anticoagulant	GH Research PLC (GHRS)
Direct Oral Anticoagulant	Merus N.V. (MRUS)
disitamab vedotin	PFIZER INC (PFE)
Divarasib	Merus N.V. (MRUS)
domvanalimab	GILEAD SCIENCES, INC. (GILD)
Doxycycline	Bausch Health Companies Inc. (BHC)
Doxycycline	Structure Therapeutics Inc. (GPCR)
Dupilumab	REGENERON PHARMACEUTICALS, INC. (REGN)
dzd8586	NYMOX PHARMACEUTICAL CORP (NYMXF)
eb01	Edesa Biotech, Inc. (EDSA)
eik1001	Eikon Therapeutics Inc. (EIKN)
Ensartinib	ADMA BIOLOGICS, INC. (ADMA)
env 105	Kairos Pharma, LTD. (KAPA)
envafolimab	Tracon Pharmaceuticals, Inc. (TCON)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
Eribulin	BioNTech SE (BNTX)
erlotinib	CG Oncology, Inc. (CGON)
Etoposide	AbbVie Inc. (ABBV)
Etoposide	Merck & Co., Inc. (MRK)
etrumadenant	Arcus Biosciences, Inc. (RCUS)
Etrumadenant	Arcus Biosciences, Inc. (RCUS)
Fianlimab	ADMA BIOLOGICS, INC. (ADMA)
Filgrastim	Filana Therapeutics Inc. (FLNA)
FOLFOX	ENANTA PHARMACEUTICALS INC (ENTA)
FOLFOX regimen	KYNTRA BIO INC. (KYNB)
fs118	F-star Therapeutics, Inc. (FSTX)
g-csf	GH Research PLC (GHRS)
Haploidentical donor bone marrow transplant	Filana Therapeutics Inc. (FLNA)
HER3-DXd	Merus N.V. (MRUS)
Ifinatamab Deruxtecan	Merus N.V. (MRUS)
ifosfamide	Black Diamond Therapeutics, Inc. (BDTX)
Immune checkpoint inhibitor	KYNTRA BIO INC. (KYNB)
Immune Checkpoint Inhibitors	ENANTA PHARMACEUTICALS INC (ENTA)
imx-110	Immix Biopharma, Inc. (IMMX)
intranasal epinephrine technology product candidates	ARS Pharmaceuticals, Inc. (SPRY)
inupadenant	iTeos Therapeutics, Inc. (ITOS)
inupadenant (EOS-850)	iTeos Therapeutics, Inc. (ITOS)
Ipatasertib	Merus N.V. (MRUS)
ITI-1549	Intra-Cellular Therapies, Inc. (ITCI)
ivonescimab	GH Research PLC (GHRS)
JNJ-90301900	Merus N.V. (MRUS)
kb-0742	Kronos Bio, Inc. (KRON)
KT-474/SAR444656	Kymera Therapeutics, Inc. (KYMR)
L-NMMA	ADMA BIOLOGICS, INC. (ADMA)
L-NMMA	Cidara Therapeutics, Inc. (CDTX)
L-NMMA	Novartis AG (NVS)
L-NMMA	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
L-NMMA	ENANTA PHARMACEUTICALS INC (ENTA)
L-NMMA	Relay Therapeutics, Inc. (RLAY)
Lazertinib	Structure Therapeutics Inc. (GPCR)
Lazertinib	Bausch Health Companies Inc. (BHC)
Lenvatinib	UNITED THERAPEUTICS Corp (UTHR)
Lenvatinib Mesylate	UNITED THERAPEUTICS Corp (UTHR)
Lepzacitinib (ATI-1777)	Aclaris Therapeutics, Inc. (ACRS)
Lesigercept	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Leucovorin	AbbVie Inc. (ABBV)
Leuprolide	ENANTA PHARMACEUTICALS INC (ENTA)
Livmoniplimab	AbbVie Inc. (ABBV)
ln-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
LN-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Lorigerlimab	MACROGENICS INC (MGNX)
Lurbinectedin	Jazz Pharmaceuticals plc (JAZZ)
Lurbinectedin	AbbVie Inc. (ABBV)
m6223	GH Research PLC (GHRS)
M6223	NEKTAR THERAPEUTICS (NKTR)
MGC018	MACROGENICS INC (MGNX)
Minocycline	Structure Therapeutics Inc. (GPCR)
montelukast	GH Research PLC (GHRS)
morf-057	Morphic Holding, Inc. (MORF)
N-803	CG Oncology, Inc. (CGON)
N-803 + Avelumab	ImmunityBio, Inc. (IBRX)
N-803 + Avelumab + PD-L1 t-haNK	ImmunityBio, Inc. (IBRX)
Nab-placlitaxel	BioNTech SE (BNTX)
NALIRIFOX	Merus N.V. (MRUS)
nexi-001	NexImmune, Inc. (NEXI)
nktr-255	GH Research PLC (GHRS)
nv-387	NANOVIRICIDES, INC. (NNVC)
nyx-2925	Aptinyx Inc. (APTX)
Olaparib	ADMA BIOLOGICS, INC. (ADMA)
Olaparib	ENANTA PHARMACEUTICALS INC (ENTA)
Olaparib	Merus N.V. (MRUS)
Oleclumab	ASTRAZENECA PLC (AZN)
olvimulogene nanivacirepvec	GENELUX Corp (GNLX)
part a - azd9291 in combination with azd6094	ASTRAZENECA PLC (AZN)
part b - azd9291 in combination with azd6094	ASTRAZENECA PLC (AZN)
part c - azd9291 in combination with azd6094	ASTRAZENECA PLC (AZN)
part d - azd9291 in combination with azd6094	ASTRAZENECA PLC (AZN)
Patritumab Deruxtecan	Merus N.V. (MRUS)
pc14586	PMV Pharmaceuticals, Inc. (PMVP)
Pemetrexed	Merus N.V. (MRUS)
Pemetrexed	Arcus Biosciences, Inc. (RCUS)
Pemetrexed	Amneal Pharmaceuticals, Inc. (AMRX)
Pemetrexed	iTeos Therapeutics, Inc. (ITOS)
Pemetrexed Disodium for Injection	Merus N.V. (MRUS)
platinum compound	GH Research PLC (GHRS)
platinum-based doublet	GILEAD SCIENCES, INC. (GILD)
poziotinib	Assertio Holdings, Inc. (ASRT)
propranolol	GH Research PLC (GHRS)
Propranolol	Bausch Health Companies Inc. (BHC)
Propranolol Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
prt2761	PORTOLA PHARMACEUTICALS INC (PTLA)
PRV-3279	MACROGENICS INC (MGNX)
Psilly	AIBOTICS, INC. (AIBT)
pumecitinib nasal spray 0.3%	TG THERAPEUTICS, INC. (TGTX)
quemliclustat	GILEAD SCIENCES, INC. (GILD)
Raludotatug Deruxtecan	Merck & Co., Inc. (MRK)
REC-4539	RECURSION PHARMACEUTICALS, INC. (RXRX)
Regorafenib	MACROGENICS INC (MGNX)
Relugolix	ENANTA PHARMACEUTICALS INC (ENTA)
reqorsa	Genprex, Inc. (GNPX)
rlyb212	Rallybio Corp (RLYB)
RP1	ENANTA PHARMACEUTICALS INC (ENTA)
rpt904	RAPT Therapeutics, Inc. (RAPT)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
rtx-240	Rubius Therapeutics, Inc. (RUBY)
rucosopasem manganese	Galera Therapeutics, Inc. (GRTX)
sacituzumab govitecan	GH Research PLC (GHRS)
Sacituzumab Govitecan	NEKTAR THERAPEUTICS (NKTR)
Sapanisertib (CB-228, formerly TAK-228)	Calithera Biosciences, Inc. (CALA)
sarilumab	REGENERON PHARMACEUTICALS, INC. (REGN)
saruparib	GH Research PLC (GHRS)
SBRT	Merus N.V. (MRUS)
Serplulimab	Merus N.V. (MRUS)
sig12d-loder	Silexion Therapeutics Corp (SLXN)
smallpox	SIGA TECHNOLOGIES INC (SIGA)
stenoparib	Allarity Therapeutics, Inc. (ALLR)
tcrα/β+	GH Research PLC (GHRS)
Tecovirimat	UNITED THERAPEUTICS Corp (UTHR)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)
temsirolimus	Black Diamond Therapeutics, Inc. (BDTX)
Teropavimab	Xencor Inc (XNCR)
timolol	GH Research PLC (GHRS)
Timolol	Bausch Health Companies Inc. (BHC)
Timolol	Structure Therapeutics Inc. (GPCR)
tislelizumab	Novartis AG (NVS)
Topotecan	BioNTech SE (BNTX)
trametinib	Novartis AG (NVS)
Tremelimumab	ADMA BIOLOGICS, INC. (ADMA)
tusamitamab ravtansine	Sanofi (SNY)
Tuvusertib	Merck & Co., Inc. (MRK)
TYRA-300 0.125 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.25 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.375 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.50 mg/kg	Tyra Biosciences, Inc. (TYRA)
ubamatamab	REGENERON PHARMACEUTICALS, INC. (REGN)
V940	Merus N.V. (MRUS)
Vemurafenib	Merus N.V. (MRUS)
Vinorelbine	ENANTA PHARMACEUTICALS INC (ENTA)
vintafolide	ENDOCYTE INC (ECYT)
vsj-110	Vanda Pharmaceuticals Inc. (VNDA)
Zelenectide pevedotin	Merus N.V. (MRUS)
zelenectide pevedotin (formerly BT8009)	BICYCLE THERAPEUTICS PLC (BCYC)
zinc gluconate	GH Research PLC (GHRS)
Zinc gluconate	Structure Therapeutics Inc. (GPCR)
zinlirvimab	Xencor Inc (XNCR)

Phase 1(175)

Drug	Company
[68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.	UNITED THERAPEUTICS Corp (UTHR)
111in-etn029	NOVARTIS AG (NVSEF)
111in-etn029	Novartis AG (NVS)
19-28z/IL-18 CAR T cells	Merus N.V. (MRUS)
225ac-etn029	NOVARTIS AG (NVSEF)
225ac-etn029	Novartis AG (NVS)
AB248	AMGEN INC (AMGN)
ABT-263	AbbVie Inc. (ABBV)
ADCT-601	ADC Therapeutics SA (ADCT)
adxs-504	OLD AYALA, INC (AYLA)
ADXS-504	Ayala Pharmaceuticals, Inc. (ADXS)
AIMab7195 (XmAb7195)	Xencor Inc (XNCR)
alk-inhibitor or ret-inhibitor	BioNTech SE (BNTX)
ALT-803	ENANTA PHARMACEUTICALS INC (ENTA)
ALX2004	ALX ONCOLOGY HOLDINGS INC (ALXO)
Aminolevulinic Acid	ENANTA PHARMACEUTICALS INC (ENTA)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
an0025	Adlai Nortye Ltd. (ANL)
anti-B7-H3 antibody conjugated to topoisomerase I inhibitor	BioNTech SE (BNTX)
anti-HER3 antibody conjugated to topoisomerase I inhibitor	BioNTech SE (BNTX)
anti-pd-1	TriSalus Life Sciences Inc. (TLSI)
Anti-STEAP1 CAR T-cells	Filana Therapeutics Inc. (FLNA)
ANX1502	Annexon, Inc. (ANNX)
AU-007	ENANTA PHARMACEUTICALS INC (ENTA)
AUTO6NG	Autolus Therapeutics plc (AUTL)
autologous genetically modified t cells	Adaptimmune Therapeutics PLC (ADAP)
Avelumab	Accustem Sciences Inc. (ACUT)
azacytidine	ENANTA PHARMACEUTICALS INC (ENTA)
AZD2936	Merus N.V. (MRUS)
azirkitug	AbbVie Inc. (ABBV)
BBO-10203	BridgeBio Oncology Therapeutics, Inc. (BBOT)
bbo-11818	BridgeBio Oncology Therapeutics, Inc. (BBOT)
BBO-11818	Merus N.V. (MRUS)
BBO-11818	ENANTA PHARMACEUTICALS INC (ENTA)
BBO-11818	BridgeBio Pharma, Inc. (BBIO)
BBO-8520	BridgeBio Oncology Therapeutics, Inc. (BBOT)
bg-60366	BeOne Medicines Ltd. (ONC)
bg-60366	BeOne Medicines Ltd. (BEIGF)
BI 764532	Merus N.V. (MRUS)
Birinapant	IGM Biosciences, Inc. (IGMS)
bispecific antibody for pd-l1	BioNTech SE (BNTX)
Bispecific antibody for PD-L1 and VEGF-A	BioNTech SE (BNTX)
BNT116	BioNTech SE (BNTX)
BNT316	BioNTech SE (BNTX)
Breast cancer vaccine (alpha-lactalbumin)	Anixa Biosciences Inc (ANIX)
BT1718	BICYCLE THERAPEUTICS PLC (BCYC)
C-TIL051	NEKTAR THERAPEUTICS (NKTR)
Capmatinib	Structure Therapeutics Inc. (GPCR)
CB-708 (ATG-037)	Calithera Biosciences, Inc. (CALA)
cc8464	Pelthos Therapeutics Inc. (PTHS)
Cemiplimab	BioNTech SE (BNTX)
Cemiplimab	Merck & Co., Inc. (MRK)
cetrelimab	Innovation Pharmaceuticals Inc. (IPIX)
cetrelimab	JOHNSON & JOHNSON (JNJ)
cetuximab	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Cetuximab	BridgeBio Pharma, Inc. (BBIO)
CFT8919	C4 Therapeutics, Inc. (CCCC)
cosibelimab	Checkpoint Therapeutics, Inc. (CKPT)
Crizotinib	ENANTA PHARMACEUTICALS INC (ENTA)
CTX-471	Compass Therapeutics, Inc. (CMPX)
CTX-8371	Compass Therapeutics, Inc. (CMPX)
Danvatirsen	ASTRAZENECA PLC (AZN)
Danvatirsen	Merus N.V. (MRUS)
deltacel	Kiromic Biopharma, Inc. (KRBP)
Digoxin	Merck & Co., Inc. (MRK)
EB-SELECT Single-Target CAR-NK Cells	Merus N.V. (MRUS)
ec1456	ENDOCYTE INC (ECYT)
elvn-002	Enliven Therapeutics, Inc. (ELVN)
enozertinib	Oric Pharmaceuticals, Inc. (ORIC)
Entinostat	Syndax Pharmaceuticals Inc (SNDX)
Epacadostat	Merus N.V. (MRUS)
Exl-111	ENANTA PHARMACEUTICALS INC (ENTA)
FOLFIRI	IGM Biosciences, Inc. (IGMS)
FOLFOX	BridgeBio Pharma, Inc. (BBIO)
FT836	FATE THERAPEUTICS INC (FATE)
GDC-1971	ENANTA PHARMACEUTICALS INC (ENTA)
GDC-6036	ENANTA PHARMACEUTICALS INC (ENTA)
gen-011	GENOCEA BIOSCIENCES, INC. (GNCA)
Gocatamig	Merus N.V. (MRUS)
H1299 Cell Lysates	CG Oncology, Inc. (CGON)
honokiol	GH Research PLC (GHRS)
Iadademstat	ENANTA PHARMACEUTICALS INC (ENTA)
IDE161	IDEAYA Biosciences, Inc. (IDYA)
ide849	IDEAYA Biosciences, Inc. (IDYA)
IDE849 (SHR-4849)	IDEAYA Biosciences, Inc. (IDYA)
imgc936	ImmunoGen, Inc. (IMGN)
imgn151	ImmunoGen, Inc. (IMGN)
incb086550	Incyte Corp. (INCY)
inlexisertib	Deciphera Pharmaceuticals, Inc. (DCPH)
investigator's treatment of choice	Genprex, Inc. (GNPX)
JANX008	Janux Therapeutics, Inc. (JANX)
jcar014	Juno Therapeutics, Inc. (JUNO)
jcar018	Juno Therapeutics, Inc. (JUNO)
jnj-86974680	Innovation Pharmaceuticals Inc. (IPIX)
jnj-86974680	JOHNSON & JOHNSON (JNJ)
JNJ-86974680	Janux Therapeutics, Inc. (JANX)
jnj-90301900	JOHNSON & JOHNSON (JNJ)
jnj-90301900	Innovation Pharmaceuticals Inc. (IPIX)
ko-2806	Kura Oncology, Inc. (KURA)
KT-253	Kymera Therapeutics, Inc. (KYMR)
lazertinib	GH Research PLC (GHRS)
LB2102	Legend Biotech Corp (LEGN)
lira-cel	Anixa Biosciences Inc (ANIX)
LY3537982	ELI LILLY & Co (LLY)
LY4175408	ELI LILLY & Co (LLY)
lymphocyte immune globulin	ENANTA PHARMACEUTICALS INC (ENTA)
MEDI5752	Merus N.V. (MRUS)
Mesna	Structure Therapeutics Inc. (GPCR)
mfolfirinox	BridgeBio Oncology Therapeutics, Inc. (BBOT)
mFOLFOX6	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Midazolam	Merck & Co., Inc. (MRK)
MK-0482	Merus N.V. (MRUS)
MK-4830	Merus N.V. (MRUS)
mobocertinib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
mobocertinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
MRG007	ArriVent BioPharma, Inc. (AVBP)
mvt-1075	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
mvt-2163	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
nalirifox	BridgeBio Oncology Therapeutics, Inc. (BBOT)
NALIRIFOX	ENANTA PHARMACEUTICALS INC (ENTA)
NALIRIFOX	BridgeBio Pharma, Inc. (BBIO)
neo-pv-01	Neon Therapeutics, Inc. (NTGN)
nt-112	ASTRAZENECA PLC (AZN)
NUV-1156	Nuvation Bio Inc. (NUVB)
NVL-330	Nuvalent, Inc. (NUVL)
NVL-520	Nuvalent, Inc. (NUVL)
nxp900	Nuvectis Pharma, Inc. (NVCT)
Oleclumab	Merus N.V. (MRUS)
Olomorasib	ELI LILLY & Co (LLY)
osimertinib	BioNTech SE (BNTX)
osimertinib	Nuvectis Pharma, Inc. (NVCT)
Osimertinib	Jazz Pharmaceuticals plc (JAZZ)
part c - azd6094 monotherapy	ASTRAZENECA PLC (AZN)
PD-L1 t-haNK	ImmunityBio, Inc. (IBRX)
Pemetrexed	BridgeBio Pharma, Inc. (BBIO)
Pemetrexed	ADMA BIOLOGICS, INC. (ADMA)
pf-08046054	PFIZER INC (PFE)
pf-08052666	PFIZER INC (PFE)
PH FDC SC	ENANTA PHARMACEUTICALS INC (ENTA)
Photodynamic Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
platinum chemotherapy	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Platinum chemotherapy	BridgeBio Pharma, Inc. (BBIO)
plogosertib (plogo)	Bio Green Med Solution, Inc. (BGMSP)
prulacabtagene leucel (prula-cel	Adicet Bio, Inc. (ACET)
Pumitamig	Merus N.V. (MRUS)
QEQ278	Novartis AG (NVS)
quaratusugene ozeplasmid	Genprex, Inc. (GNPX)
ramucirumab	Genprex, Inc. (GNPX)
retifanlimab	Incyte Corp. (INCY)
rinzimetostat	Oric Pharmaceuticals, Inc. (ORIC)
rmc-5127	REVOLUTION MEDICINES, INC. (RVMD)
Rucaparib	ENANTA PHARMACEUTICALS INC (ENTA)
S241656	IGM Biosciences, Inc. (IGMS)
sar408701	Sanofi (SNY)
sigvotatug vedotin	PFIZER INC (PFE)
tas3351	CG Oncology, Inc. (CGON)
tcellvax	Regen BioPharma Inc (RGBPP)
TNG260	Tango Therapeutics, Inc. (TNGX)
tno155 in combination with egf816	Novartis AG (NVS)
tpx-0131	Turning Point Therapeutics, Inc. (TPTX)
trametinib	Deciphera Pharmaceuticals, Inc. (DCPH)
TYRA-300	Tyra Biosciences, Inc. (TYRA)
velinotamig	Cullinan Therapeutics, Inc. (CGEM)
Veto Cell	Cell Source, Inc. (CLCS)
Vibostolimab	Merus N.V. (MRUS)
wtx-712	Werewolf Therapeutics, Inc. (HOWL)
wtx-921	Werewolf Therapeutics, Inc. (HOWL)
XB010	EXELIXIS, INC. (EXEL)
XmAb7195	Xencor Inc (XNCR)
xmt-2056	Mersana Therapeutics, Inc. (MRSN)
yl201	AMGEN INC (AMGN)
Zidesamtinib	Nuvalent, Inc. (NUVL)
zimberelimab	GILEAD SCIENCES, INC. (GILD)
zl-1310	AMGEN INC (AMGN)

Preclinical(47)

Drug	Company
225ac-psma-62	POINT Biopharma Global Inc. (PNT)
adi-100	Aditxt, Inc. (ADTX)
adxs-503	OLD AYALA, INC (AYLA)
adxs-503	OS Therapies Inc (OSTX)
aimab7195	Aimmune Therapeutics, Inc. (AIMT)
al101	OLD AYALA, INC (AYLA)
allereye	Bluejay Diagnostics Inc. (BJDX)
Anti-Rejection Anti-Viral Veto Cell	Cell Source, Inc. (CLCS)
APG222	Apogee Therapeutics, Inc. (APGE)
ast-vac2	ASTERIAS BIOTHERAPEUTICS, INC. (AST)
ATI-9494	Aclaris Therapeutics, Inc. (ACRS)
ATNM-400	Actinium Pharmaceuticals, Inc. (ATNM)
BCR-ABL TKI	Theseus Pharmaceuticals, Inc. (THRX)
birch pollen allergy immunotherapy	MYMETICS CORP (MYMX)
BP1003	BIO-PATH HOLDINGS, INC. (BPTH)
CAR-T and Veto Cell combination (CAR-T Veto Cell therapy)	Cell Source, Inc. (CLCS)
cdx-301	CARDAX, INC. (CDXI)
chi3l1 bsabs	Ocean Biomedical, Inc. (OCEA)
chi3l1 mab	Ocean Biomedical, Inc. (OCEA)
CLD-301 (AAA)	Calidi Biotherapeutics Inc. (CLDI)
CPI-935	Corvus Pharmaceuticals, Inc. (CRVS)
cypcaps	PharmaCyte Biotech, Inc. (PMCB)
EO-1022	Elevation Oncology, Inc. (ELEV)
EPS-3903	ENANTA PHARMACEUTICALS INC (ENTA)
Fourth-Generation EGFR Inhibitor	Theseus Pharmaceuticals, Inc. (THRX)
fyarro + adagrasib	Whitehawk Therapeutics, Inc. (WHWK)
HBS-102	Harmony Biosciences Holdings, Inc. (HRMY)
hicar-t	Orgenesis Inc. (ORGS)
ht-004	Hoth Therapeutics, Inc. (HOTH)
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
KRAS program	Cogent Biosciences, Inc. (COGT)
KYV-201	Intellia Therapeutics, Inc. (NTLA)
lyoccp	NULIFE SCIENCES, INC. (NULF)
mink-215	MiNK Therapeutics, Inc. (INKT)
oncr-021	Oncorus, Inc. (ONCR)
oncr-788	Oncorus, Inc. (ONCR)
Pan-mutant BRAF degrader program (proprietary)	Nurix Therapeutics, Inc. (NRIX)
Pan-mutant BRAF program (mutant BRAF degraders)	Nurix Therapeutics, Inc. (NRIX)
pf743	Pfenex Inc. (PFNX)
pf745	Pfenex Inc. (PFNX)
qbm-001	Q BioMed Inc. (QBIO)
repurposed drug for cns cancer	Cosmos Health Inc. (COSM)
THE-349	Theseus Pharmaceuticals, Inc. (THRX)
til	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
ttx-sipdl1	Transcode Therapeutics, Inc. (RNAZ)
Veto Cell technology	Cell Source, Inc. (CLCS)
zegocractin (oral, preclinical administration)	CalciMedica, Inc. (CALC)

Unknown(22)

Drug	Company
ADXS-503	Ayala Pharmaceuticals, Inc. (ADXS)
Ainos Flora (VOC POCT)	Ainos Inc. (AIMD)
Alinity® m and m2000™	ABBOTT LABORATORIES (ABT)
Alova	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
AR101	AYTU BIOPHARMA, INC (AYTU)
bengay heat therapy	JOHNSON & JOHNSON (JNJ)
cardiamp cell therapy	BioCardia, Inc. (BCDA)
Claria System	Organon & Co. (OGN)
ebvallo	Atara Biotherapeutics, Inc. (ATRA)
Equine All-in-One Plus™	BIOADAPTIVES, INC. (BDPT)
FastHyb	Twist Bioscience Corp (TWST)
Helix™ minimally invasive intramyocardial therapeutic delivery platform	BioCardia, Inc. (BCDA)
NaturaComplete™	BIOADAPTIVES, INC. (BDPT)
neutrogena light therapy aging mask+	JOHNSON & JOHNSON (JNJ)
nspfa cardiac surgical system	Pulse Biosciences Inc Common Stock (DE) (PLSE)
Oral C5 Inhibitor	BIOCRYST PHARMACEUTICALS INC (BCRX)
Portfolio of TGR5 agonist compounds	ARDELYX, INC. (ARDX)
puzolcabtagene autoleucel	PRECISION BIOSCIENCES INC (DTIL)
SIUS Gamma	REPLIGEN CORP (RGEN)
vigiv	Emergent BioSolutions Inc. (EBS)
xolair	Novartis AG (NVS)
xolair	NOVARTIS AG (NVSEF)

BLA Filed(2)

Drug	Company
anaphylm	Aquestive Therapeutics, Inc. (AQST)
ar101	Aimmune Therapeutics, Inc. (AIMT)

Early Phase 1(1)

Drug	Company
VTP-600	Barinthus Biotherapeutics plc. (BRNS)

N/A(8)

Drug	Company
Crizotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Erlotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
First-line antihypertensive single-pill combination	Merus N.V. (MRUS)
LockBody technology platform	Centessa Pharmaceuticals plc (CNTA)
Pemetrexed Disodium	Crinetics Pharmaceuticals, Inc. (CRNX)
Pemetrexed Disodium	Amneal Pharmaceuticals, Inc. (AMRX)
Yishen Qutong Granules	Merus N.V. (MRUS)
Yishen Qutong Simulant Granules	Merus N.V. (MRUS)

Phase 1/Phase 2(56)

Drug	Company
[177lu]lu-dota-tate	Novartis AG (NVS)
[68ga]ga-dota-tate	Novartis AG (NVS)
[68Ga]Ga-DOTA-TATE	Novartis AG (NVS)
ABV-1519	ABVC BIOPHARMA, INC. (ABVC)
bnt323	BioNTech SE (BNTX)
BNT326	BioNTech SE (BNTX)
BNT327	BioNTech SE (BNTX)
Budigalimab	AbbVie Inc. (ABBV)
cetuximab	Novartis AG (NVS)
cetuximab	Novartis AG (NVS)
cetuximab	REVOLUTION MEDICINES, INC. (RVMD)
Cetuximab	ELI LILLY & Co (LLY)
chemotherapy	Krystal Biotech, Inc. (KRYS)
Chemotherapy	Merus N.V. (MRUS)
cln-081	Cullinan Therapeutics, Inc. (CGEM)
cr-001	CRESCENT BIOPHARMA, INC. (CBIO)
db-oto	REGENERON PHARMACEUTICALS, INC. (REGN)
dji136	Novartis AG (NVS)
dji136	NOVARTIS AG (NVSEF)
dzd6008	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Gocatamig	Merck & Co., Inc. (MRK)
hpn328	Harpoon Therapeutics, Inc. (HARP)
ide397	AMGEN INC (AMGN)
ifinatamab deruxtecan	Merck & Co., Inc. (MRK)
Itraconazole	ASTRAZENECA PLC (AZN)
jdq443	Novartis AG (NVS)
kb707	Krystal Biotech, Inc. (KRYS)
loxo-292	ELI LILLY & Co (LLY)
m1774	GH Research PLC (GHRS)
MCLA-129	Merus N.V. (MRUS)
Neladalkib	Nuvalent, Inc. (NUVL)
opnurasib	NOVARTIS AG (NVSEF)
opnurasib	Novartis AG (NVS)
oral repotrectinib	Turning Point Therapeutics, Inc. (TPTX)
oral repotrectinib	TG THERAPEUTICS, INC. (TGTX)
osimertinib	Genprex, Inc. (GNPX)
osimertinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
osimertinib	SUNSHINE BIOPHARMA INC. (SBFM)
Osimertinib	Merus N.V. (MRUS)
pemetrexed	REVOLUTION MEDICINES, INC. (RVMD)
platinum-based chemotherapy	REGENERON PHARMACEUTICALS, INC. (REGN)
platinum-based chemotherapy	Genprex, Inc. (GNPX)
platinum-based doublet chemotherapy	REGENERON PHARMACEUTICALS, INC. (REGN)
Ramucirumab	ELI LILLY & Co (LLY)
REC-617	RECURSION PHARMACEUTICALS, INC. (RXRX)
sd-101	TriSalus Life Sciences Inc. (TLSI)
tcr-t library	Alaunos Therapeutics, Inc. (TCRT)
tislelizumab	Novartis AG (NVS)
TNG456	Tango Therapeutics, Inc. (TNGX)
TNG462	Tango Therapeutics, Inc. (TNGX)
TNG908	Tango Therapeutics, Inc. (TNGX)
tno155	Novartis AG (NVS)
tno155	Novartis AG (NVS)
v2act immunotherapy	GENELUX Corp (GNLX)
Vinorelbine	ELI LILLY & Co (LLY)
wsd0922-fu	SUNSHINE BIOPHARMA INC. (SBFM)

Phase 2/Phase 3(11)

Drug	Company
blinatumomab	GH Research PLC (GHRS)
CA-170	CURIS INC (CRIS)
iza-bren	BRISTOL MYERS SQUIBB CO (BMY)
nogapendekin alfa	GH Research PLC (GHRS)
osimertinib	AbbVie Inc. (ABBV)
Pemetrexed	AbbVie Inc. (ABBV)
Pemetrexed	BioNTech SE (BNTX)
pq grass	Relief Therapeutics Holding SA (RLFTF)
screening platform	GH Research PLC (GHRS)
sil204	Silexion Therapeutics Corp (SLXN)
surufatinib	HUTCHMED (China) Limited (HCM)

Phase 4(43)

Drug	Company
5-Flurouracil	Merus N.V. (MRUS)
5-FU	Merus N.V. (MRUS)
adrenaline	ARS Pharmaceuticals, Inc. (SPRY)
Avelumab	ENANTA PHARMACEUTICALS INC (ENTA)
bms-986012	BRISTOL MYERS SQUIBB CO (BMY)
bms-986489	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986504	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986525	BRISTOL MYERS SQUIBB CO (BMY)
CAPOX chemotherapy	Merus N.V. (MRUS)
Cetuximab	IGM Biosciences, Inc. (IGMS)
Chemotherapy Regimen	Merus N.V. (MRUS)
Concurrent chemotherapy	Merus N.V. (MRUS)
Conditioning chemotherapy	Merus N.V. (MRUS)
Diclofenac Potassium	Assertio Holdings, Inc. (ASRT)
Enfortumab Vedotin	Fulgent Genetics Inc. (FLGT)
Fexofenadine	Sanofi (SNY)
fexofenadine hcl	Sanofi (SNY)
Fexofenadine HCL and pseudoephedrine HCL	Sanofi (SNY)
Fianlimab	ENANTA PHARMACEUTICALS INC (ENTA)
FOLFOX chemotherapy	Merus N.V. (MRUS)
IBI363 + Chemotherapy	Merus N.V. (MRUS)
Leuprolide	Myovant Sciences Ltd. (MYOV)
Lymphodepletion Chemotherapy	Merus N.V. (MRUS)
monalizumab	GH Research PLC (GHRS)
Monalizumab	ASTRAZENECA PLC (AZN)
Montelukast	Structure Therapeutics Inc. (GPCR)
mRNA-1769	Moderna, Inc. (MRNA)
neffy	ARS Pharmaceuticals, Inc. (SPRY)
NG-350A IV administration	Merus N.V. (MRUS)
Omalizumab	ENANTA PHARMACEUTICALS INC (ENTA)
osimertinib	ASTRAZENECA PLC (AZN)
Osimertinib 80mg/40mg	ASTRAZENECA PLC (AZN)
Pegfilgrastim	Structure Therapeutics Inc. (GPCR)
Pemetrexed	ASTRAZENECA PLC (AZN)
Platinum chemotherapy	Merus N.V. (MRUS)
ponatinib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
ponatinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Relatlimab	BRISTOL MYERS SQUIBB CO (BMY)
saruparib	ASTRAZENECA PLC (AZN)
Single agent chemotherapy	Merus N.V. (MRUS)
Single Cycle Intensive Chemotherapy	Merus N.V. (MRUS)
SKB571 for injection	Merus N.V. (MRUS)
Tandem 3 Cycle Intensive Chemotherapy	Merus N.V. (MRUS)

Compare drugs

abrilada vs aBSI (Automated Bone Scan Index)abrilada vs acam2000 abrilada vs acetylcysteine

Frequently asked questions

How many drugs are in development for ALL?

BioSniper tracks 1118 drugs in development for ALL across 292 companies.

How many clinical trials target ALL?

There are 2 clinical trials targeting ALL tracked by BioSniper.

What is the prevalence of ALL?

The estimated prevalence of ALL is approximately 75.0 per 100,000 population.

Deep-dive into ALL

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis